IP Library Granted Patent US 7,897,742
Granted Patent B2
US 7,897,742 · App. 11/809,756 · Granted Mar 1, 2011

Twin-arginine translocation in

Assignee: Danisco US Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,897,742
App. No.
11/809,756
Granted
Mar 1, 2011
Kind
B2
Abstract

Described herein are methods to enhance protein secretion in a host cell. In preferred embodiment, the host cell is a gram-positive microorganism such as a Bacillus . In another preferred embodiment, the host cell is a gram-negative microorganism. Preferably the gram-negative microorganism is an Escherichia coli or a member of the genus Pantoea . Protein secretion may be enhanced by the overexpression of protein components of the Tat pathway. Alternatively, secretion of foreign proteins can be selectively enhanced by forming a chimeric polypeptide comprising a tat signal sequence and the protein of interest. In a preferred embodiment, the tat signal sequence is selected from phoD or LipA.

Claims (24)

1. An isolated nucleic acid molecule comprising a first nucleotide sequence encoding a Bacillus subtilis lipase LipA signal sequence operatively linked to a second nucleotide sequence encoding a heterologous polypeptide.

2. A recombinant expression vector comprising a first DNA sequence encoding a Bacillus subtilis lipase LipA signal sequence operatively linked to a second DNA sequence encoding a heterologous polypeptide.

3. A host cell containing a recombinant expression vector comprising a first DNA sequence encoding a Bacillus subtilis lipase LipA signal sequence operatively linked to a second DNA sequence encoding a heterologous polypeptide.

4. The host cell of claim 3 , wherein said polypeptide is not naturally associated with a secretion signal peptide.

5. A method for producing a polypeptide, comprising culturing a host cell containing a recombinant expression vector comprising a first DNA sequence encoding a Bacillus subtilis lipase LipA signal sequence operatively linked to a second DNA sequence encoding a heterologous polypeptide is produced by the host cell, wherein the host cell comprises a nucleic acid encoding TatAd protein and a nucleic acid encoding TatCd protein.

6. The method of claim 5 , wherein the polypeptide is secreted by the host cell into a culture medium.

7. The method of claim 6 , further comprising recovering the polypeptide from the culture medium.

8. A method for producing a heterologous polypeptide in bacteria comprising:

(a) culturing bacterial cells that (i) lack a functional TatCy gene and (ii) contain a recombinant expression vector comprising a first DNA sequence encoding a Bacillus subtilis lipase LipA signal sequence operatively linked to a second DNA sequence encoding a heterologous polypeptide such that the heterologous polypeptide is produced by the cells, wherein the cells comprise a nucleic acid encoding TatAd protein and a nucleic acid encoding TatCd protein; and

(b) recovering the heterologous polypeptide from the periplasm or the culture medium.

9. A process for producing a heterologous polypeptide in bacteria comprising:

(a) culturing bacterial cells that (i) overexpress one or more B. subtilis Tat system genes encoding membrane-bound components thereof and (ii) contain a recombinant expression vector comprising a first DNA sequence encoding a Bacillus subtilis lipase LipA signal sequence operatively linked to a second DNA sequence encoding a heterologous polypeptide such that the heterologous polypeptide is produced by the cells, wherein the cells comprise a nucleic acid encoding TatAd protein and a nucleic acid encoding TatCd protein; and

(b) recovering the heterologous polypeptide from the periplasm or the culture medium.

10. The nucleic acid molecule of claim 1 , wherein the heterologous polypeptide is an enzyme.

11. The nucleic acid molecule of claim 10 , wherein the enzyme is selected from the group consisting of a protease, cellulase, amylase, lipase, and hydrolase.

12. The nucleic acid molecule of claim 11 , wherein the enzyme is a protease.

13. The nucleic acid molecule of claim 11 , wherein the enzyme is a cellulase.

14. The nucleic acid molecule of claim 11 , wherein the enzyme is an amylase.

15. The nucleic acid molecule of claim 11 , wherein the enzyme is a lipase.

16. The nucleic acid molecule of claim 11 , wherein the enzyme is a hydrolase.

17. The recombinant expression vector of claim 2 , wherein the heterologous polypeptide is an enzyme.

18. The recombinant expression vector of claim 17 , wherein the enzyme is selected from the group consisting of a protease, cellulase, amylase, lipase, and hydrolase.

19. The recombinant expression vector of claim 18 , wherein the enzyme is a protease.

20. The recombinant expression vector of claim 18 , wherein the enzyme is an amylase.

Assignments (1)
CHANGE OF NAME Recorded Jul 20, 2010
From: GENENCOR INTERNATIONAL, INC.
To: DANISCO US INC.
Reel/Frame 024716/0499 →
Continuity (3)
Division 09954737 · Sep 17, 2001
Provisional Application 60233610 · Sep 18, 2000
Related Publication 20080248525A1 · Oct 9, 2008